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Prospective, Randomized Trial of 
Doppler-Assisted Subclavian Vein 
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ABSTRACT Objectice: To examine the rate of success and 
complications of Doppler-guided subclavian vein catheter inser- 
tion compared with standard insertion in patients considered a t  
high risk for failure. Design: Prospective, randomized, crossover 
trial. Setting: University-affiliated tertiary care medical center. 
Patients: Two hundred forty patients were enrolled in the study. 
Patients were stratified for 3 known risk factors: (1) prior surgery 
in the subclavian vein region, (2) prior radiotherapy a t  the 
attempted catheterization site, and (3) a n  abnormal weight- 
height ratio. Interuentions: Subclavian vein catheterization was 
performed either in standard or Doppler-guided fashion using the 
Smart Needle (Peripheral Systems Group, RIountain View, 
Calif), which is a Doppler probe at the tip of a cannulating needle. 
If subclavian vein catheterization was unsuccessful after 2 
attempts, patients were crossed over to the other technique. Main 
Outcome Measure: Successful cannulation of the subclavian vein. 
Results: The success rate, either as an initial technique or as a 
salvage technique and complication rate were not significantly 
different with use of the Smart Needle. A subgroup of physicians 
had a significantly lower success rate using the Smart Needle. 
Conclusions: Doppler guidance did not increase the success rate 
or decrease the complication rate of subclavian vein catheteriza- 
tion when compared with the standard technique in high-risk 
patients. Doppler guidance was not more useful than the stan- 
dard technique as a salvage technique following a previous 
failure of catheterization. Furthermore, real-time Doppler guid- 
ance of subclavian vein catheterization is a technique that is 
highly operator dependent. (Arch Surg 133:1089-1093, 1998) 
COMMENT: This is a large, prospective, randomized, 
crossover clinical trial from a single institution using a 
neiv product that was reported to enhance cannulation of 
the subclavian vein in routine, elective catheter place- 
ment. The device is an 18-gauge needle fitted with a 
real-time Doppler sensor. It provides information regard- 
ing its proximity to  vascular structures and may “permit 
the differentiation of venous and arterial signals.” In this 
well-done study, there was no benefit to  the Doppler 
device. 
The authors comment on a previous meta-analysis that 
suggested opposite findings. The operators in the single- 
institution study were experienced fellows (postgraduate 
years 6 to 10) using a dedicated procedure suite for the 
insertion of long-term subclavian venous access catheters. 
The present study seems to highlight the differences 
between a single prospective randomized trial and a 
rneta-analysis. The referred meta-analysis pooled eight 
studies done primarily in critically ill and general medi- 
cal-surgical patients. In all but two studies, the internal 
jugular vein was the access site; most operators were 
junior residents, but two studies used anesthesiologists. 
The comparison between the single-center trial and the 
meta-analysis may represent an “oranges to apples” phe- 
nomenon. The Doppler-assisted device for locating venous 
access may represent a neiv technology in search of an 
appropriate application. 
Lynne hI. Murphy, hlSN, RN, CNSN 
Efficacy of Antiseptic-Impregnated 
Central Venous Catheters in Preventing 
Catheter-Related Bloodstream Infection: 
A Meta-Analysis 
DL Veenstra, S Saint, S Saha, et a1 
Department of Pharmacy, University of Washington, 
Seattle 
ABSTRACT: Context: Central venous catheters impregnated 
with chlorliexidine and silver sulfadiazine have recently been 
introduced for the prevention of catheter-related infections. How- 
ever, there remains some uncertainty regarding the efficacy of 
these catheters because of conflicting reports in the literature. 
Objective: To evaluate the efficacy of chlorhexidine-silver sulfadi- 
azine-impregnated central venous catheters in the prevention of 
catheter-related bloodstream infection. Data Sources: Studies 
identified from a computerized search of the RIEDLINE database 
from January 1966 to January 1998, reference lists of identified 
articles, and queries of principal investigators and the catheter 
manufacturer. Study Selection: Randomized trials comparing 
chlorhexidine-silver sulfadiazine-impregnated central venous 
catheters with nonimpregnated catheters were included. The 
outcomes assessed were catheter colonization and catheter-re- 
lated bloodstream infection confirmed by catheter culture. Data 
Extraction: Twelve studies met the inclusion criteria for catheter 
colonization and included a total of 2611 catheters. Eleven 
studies with a total of 2603 catheters met the inclusion criteria 
for catheter-related bloodstream infection. Most patients in these 
studies were from groups considered to be at high risk for 
catheter-related infections. Summary statistics were calculated 
using RIantel-Haenszel methods under a fixed-effects model. 
Data Synthesis: The summary odds ratio for catheter colonization 
was 0.44 (95% confidence interval [CI], 0.36 to 0.54; p < .001), 
indicating a significant decrease in catheter colonization associ- 
ated with impregnated catheters. The studies examining the 
outcome of primary interest, catheter-related bloodstream infec- 
tion, had a summary odds ratio of 0.56 (95% CI, 0.37 to 0 . 8 4 ; ~  = 
.005). Conclusions: Central venous catheters impregnated with a 
combination of chlorhexidine and silver sulfadiazine appear to be 
effective in reducing the iiicidence of both catheter colonization 
and catheter-related bloodstream infection in patients a t  high 
risk for catheter-related infections. (JAhIA 281:261-267, 1999) 
COMMENT: This meta-analysis was well conducted. 
However, the conclusion was predictable. In each of the 11 
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trials, the bloodstream infection rate was a t  least arith- 
metically lower in the group using the impregnated cath- 
eter. If there were truly no difference between the two 
catheters, the probability of this happening by chance is 
the same as that of having a coin come up all heads or all 
tails after 11 tosses, namely <.001. Unless the cost of this 
catheter is extraordinarily high, there appears to be ample 
evidence to justify its routine use. 
The authors did not hand-search individual medical 
journals in their effort to find all the  pertinent articles, as 
this process is very time consuming. Sometime in the next 
century, such a database will be routinely available. The 
Cochrane Collaboration, an  organization dedicated to the 
production of quality systematic reviews, is currently 
hand-searching all medical journals. Anyone interested in 
learning a more about the systematic review process is 
invited to join them. 
Ronald L. Koretz, MD 
A Comparison of Two Antimicrobial- 
Impregnated Central Venous Catheters 
RO Darouiche, I1 Raad, SO Heard, et a1 
Department of Medicine, Buylor College of Medicine and 
Veterans Affairs Medical Center, Houston 
ABSTRACT Background: The use of central venous catheters 
impregnated with either minocycline and rifampin or chlorhexi- 
dine and silver sulfadiazine reduces the rates of catheter coloni- 
zation and catheter-related bloodstream infection as  compared 
with the use of unimpregnated catheters. We compared the rates 
of catheter colonization and catheter-related bloodstream infec- 
tion associated with these two kinds of antiinfective catheters. 
Meethods: We conducted a prospective, randomized clinical trial in 
12 university-affiliated hospitals. High-risk adult patients in 
whom central venous catheters were expected to remain in place 
for three or more days were randomly assigned to undergo 
insertion of polyurethane, triple-lumen catheters impregnated 
with either minocycline and rifampin (on both the luminal and 
external surfaces) or chlorhexidine and silver sulfadiazine (on 
only the external surface). After their removal, the tips and 
subcutaneous segments of the catheters were cultured by both 
the roll-plate and the sonication methods. Peripheral-blood cul- 
tures were obtained if clinically indicated. Results: Of 865 cath- 
eters inserted, 738 (85%) produced culture results that could be 
evaluated. The clinical characteristics of the patients and the risk 
factors for infection were similar in the two groups. Catheters 
impregnated with minocycline and rifampin were 1/3 as likely to 
be colonized as catheters impregnated with chlorhexidine and 
silver sulfadiazine (28 of 356 catheters [7.9%1 us 87 of 382 
[22.89], p < .001), and catheter-related bloodstream infection 
was 1/12 as likely in catheters impregnated with minocycline and 
rifampin (1 of 356 I0.381, us 13 of 382 r3.491 for those impreg- 
nated with chlorhexidine and silver sulfadiazine; p < .002). 
Conclusions: The use of central venous catheters impregnated 
with minocycline and rifampin is associated with a lower rate of 
infection than the use of catheters impregnated with chlorhexi- 
dine and silver sulfadiazine. (N Engl J RIed 34O:l-8, 1999) 
COMMENT: It  is estimated that 150,000 cases of central 
venous catheter-related bloodstream infections (CVC- 
BSIs) occur each year in the United States, a t  a cost of 
$30,000 per case. Current research on the prevention of 
CVC-BSIs has focused on catheters impregnated with 
antimicrobials. The minocycline/rifampin (hI/R)- and 
chlorhexidindsilver sulfadiazine (C/SS)-coated catheters 
are currently available, and each has been shown to 
reduce the rate of CVC colonization and CVC-BSI when 
compared with uncoated catheters. 
Darouiche and colleagues performed a well-designed 
study that compared h m -  with C/SS-impregnated CVCs 
in patients requiring venous access for more than 3 days 
via a new venipuncture site. The h.yR-CVC had a signifi- 
cantly lower rate of colonization than the C/SS-CVC: 7.9% 
us 22.8521, respectively. This protective effect was seen 
regardless of the amount of time the catheters remained 
in  place. CVC-BSIs occurred in 14 patients, with all but 
one occurring in the C/SS-CVC group. The rate of CVC- 
BSI was 0.3 us 4.1 per 1000 catheter days for hUR- and 
C/SS-CVCs, respectively. The hUR-CVCs were signifi- 
cantly protective against CVC-BSI because of coaylase- 
negative staphylococci. 
This study suggests that  htvR-CVC can reduce the rate 
of infectious complications associated with temporary 
CVC when compared with C/SS-CVC and that this should 
result in a decrease in the morbidity, mortality, and cost 
associated with managing these complications. This con- 
clusion, however, must be made with a few words of 
caution. First, the rate of catheter colonization and CVC- 
BSI for the C/SS-CVC seen in this study was higher than 
that reported by others (hlaki DG, et  al: Ann Intern hIed 
127:257-266, 1997). Next, although the randomization 
scheme was appropriate and blinding was maintained in  
the packaging of the two catheters, it must be noted that 
the two catheters are different in appearance. This may 
have introduced a bias in the management of one catheter 
over another because two of the authors developed the 
BUR-CVC and the manufacturer of this catheter spon- 
sored the study. Finally, although the use of these cathe- 
ters has not resulted in the development of bacterial 
antimicrobial resistance, this issue remains an  important 
concern. Having said this, the results of this and other 
studies suggest that  antibiotic-impregnated catheters 
may improve the overall care of patients. Hospitals that  
choose to use these catheters should monitor them closely 
to assure that their use results in the desired outcomes 
and that untoward effects are not seen. 
Deborah Katz-Scott, RN, CRNI 
Douglas L. Seidner, RID, CNSP, FACG 
A Reevaluation of the Radiographically 
Detectable Complications of 
Percutaneous Venous Access lines 
Inserted by Four Subcutaneous 
Approaches 
JA Miller, S Singireddy, P Maldjian, et a1 
Department of Radiology, The University of Medicine 
und Dentistry of New Jersey, Neivarlz 
ABSTRACT As a result of prior studies elucidating the poten- 
tial complications associated with the use of central venous access 
lines, the Food and Drug Administration and the manufacturers 
themselves have published guidelines and warnings outlining 
these dangers and describing the safest insertion techniques. We 
will attempt to determine whether this improved education has 
altered the number and type of complications, comparing the 
results from different types of hospitals, among the various 
medical services and among operators with varying degrees of 
experience. This is a prospective analysis of all central venous 
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pressure (CVP) and Swanz-Ganz catheters (SGCs) inserted 
between July 1, 1995, and February 30, 1996, at a regional 
Veteran’s Affairs hospital and an inner city university medical 
center. Three hundred seventy-five inpatients underwent 417 
new percutaneous venous catheter placements while in the med- 
ical or surgical intensive care units or in the general care wards. 
A portable chest radiograph was obtained immediately after each 
procedure, and the position of the catheter and any associated 
complications were recorded, initially by the radiology resident in 
the emergency suite and subsequently as confirmed by a chest 
radiology attending. CVP lines were considered malpositioned 
when the tip was not located in the superior vena cava, and SGCs 
were recorded as misplaced when the tip was not found within the 
main, left main, right main, or either lower lobe pulmonary artery 
within 2 cm of the cardiac border. For patients undergoing CVP 
line placement, the right atrium was the most frequent site of tip 
maIposition with 38 of 69 total misplacements (55%), whereas for 
SGCs, 22 of 55 malplacements (40%) were too distal in a lower 
lobe pulmonary artery. Only 1 of 248 CVP lines resulted in a 
pneumothorax (m 0.4101, whereas 6 of 169 SGC insertions 
caused a PTX (3.581, a significant difference (p = .019). Five of 
192 catheters (2.6%) placed via a n  internal jugular approach 
resulted in PTX, whereas only 2 of 150 subclavian cannulations 
(1.3%) caused this complication, revealing a trend, but not reach- 
ing statistical significance ( p  = .473). However, there was a 
significant decrease in the rate of catheter misplacements in the 
third part of the month compared with the first 20 days (35% us 
24%; p = .031), and the Veteran’s Affairs hospital displayed a 
trend toward more complications for SGC insertions. than the 
university hospital (47% us 32%), but not for CVP lines. In 
general, individual medical and surgical services displayed a 
similar frequency of complications (29% to 38%), except for CVP 
lines inserted in the medical intensive care unit. Venous access 
catheter tip malpositions are very common in all settings, but 
easily recognized by radiography, whereas PTXS are unusual. In 
contrast to most older studies, PTXS are more frequently 
observed with internal jugular as opposed to subclavian cannu- 
lations and with SGCs rather than CVP lines. However, our data 
support prior studies that the right atrium and distal right lower 
lobe pulmonary artery are the most common sites for CVP and 
SGC misplacement, respectively, and that there is an improve- 
ment in  success rates with increasing operator experience. ( h e r  
Surg 65:125-130,1999) 
COMMENT: A prospective analysis of 169 Swan-Ganz 
catheter (SGC) and 248 central venous pressure (CVP) 
catheter insertions was undertaken to determine if 
improved education and practitioner experience affected 
rates of insertion-related complications. Previous studies 
have shown that subclavian vein insertions have the 
highest rate of pneumothorax. However, results from this 
study found a higher rate of pneumothorax from the 
cannulation of internal jugular veins (2.6% us 1.3%, 
although not statistically significant). The authors’ pro- 
posed explanation for this discrepancy was based on the 
assumption that catheter manufacturers and schools of 
medicine now have extensive educational materials avail- 
able regarding the proper technique for subclavian vein 
cannulation, thereby improving an inexperienced clini- 
cian’s knowledge and minimizing the risk of complications 
associated with that approach. 
In this study, a statistically significant greater rate 
of pneumothorax was found with SGC insertions com- 
pared with CVP insertions (3.6% us 0.4%; p = .019). 
This finding has not been previously reported in the 
literature. The authors attributed this to the more 
emergent nature of a SGC insertion and proposed the 
universal use of cordis sheath introducers to minimize 
this complication. 
Other findings revealed that 67% of right internal 
jugular vein insertions resulted with catheter tip malpo- 
sition in the right atrium and that the rate of catheter 
malposition was significantly less in the last third of a 
month compared with the first 20 days (35% us 24%; p = 
.031), thus, inferring that clinician experience does impact 
the rate of insertion-related complications. It is interest- 
ing to  note that the authors’ rate of life-threatening 
complications dramatically improved from the findings 
published in the literature 10-20 years ago, again adding 
credence to their assertion that improved techniques and 
education positively affected outcomes. Finally, regarding 
the high rate of catheter malposition, the problem was 
readily identified in the postinsertion radiographs and 
could be remedied with catheter retraction into the appro- 
priate vessel. 
Susan T. Jepsen, RN, CNSN 
